At an early stage of hospitalization before five days, in a common room; It is at this time that the plasma must be transfused so that the risk of a patient entering intensive care or use of a respirator can be reduced.
This was stated by Dr. Óscar Echeverría, from the National Blood Program, who also stated that there is evidence of 30% to 38% improvement in patients. It even reduces mortality.
What are the requirements for this therapy, which is still in the experimental phase, to have favorable results?
A patient who should be benefited with this therapy must unfailingly have a positive COVID-19 test. With the result, it is necessary to proceed to the early transfusion indication.
Plasma must have a high antibody index, for which the protocols of clinical trials carried out internationally are applied.
Donate convalescent plasma
Plasma therapy of convalescent people (those who have recovered from COVID-19) is an experimental treatment that several countries are using for those who have the coronavirus disease. Those convalescing have antibodies (proteins the body uses to fight infection) in their blood. Plasma is the liquid part of the blood.
“If you have recovered from COVID-19, you may be able to help patients who are battling the infection by donating your plasma. As a result of your infection, your plasma now contains antibodies to COVID-19, which is one of the ways your immune system fought the virus when you were sick. His plasma is now called convalescent plasma ”, they express from the National Blood Program.
For more information, about who and how you can donate, you can contact:
Al mail [email protected]
—
